Cancer Blood Test

Centre proposes changes in Drug Rules to standardise blood product testing

The Union Health Ministry has proposed to amend the Drugs Rules, 1945, to align regulatory requirements for testing blood products with internationally accepted pharmacopoeial standards and remove testing requirements not warranted under global best practices. It has issued a draft gazette notification, inviting public comments on a proposal to amend paragraph G (testing of blood products), Part XII C, Schedule F of the Drugs Rules 1945. "The proposed amendment seeks to align regulatory requirements for testing blood products with internationally accepted pharmacopoeial standards and to remove additional testing requirements on products that are not warranted under global best practices," the ministry said. According to the official monographs of Human Plasma for Fractionation in the Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), United States Pharmacopeia (USP), and European Pharmacopoeia (EP), stringent testing protocols are prescribed for pooled human plasma. Under these

World Leukaemia Day: Why early detection is the key to saving lives

From fatigue and bruising to recurrent infections, leukaemia symptoms are often neglected. World Leukaemia Day draws attention to the importance of early detection and diagnosis

This new blood test could spot cancer up to 3 years before symptoms

A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially transforming early treatment and survival rates

Fortis launches institute for specialised treatment of blood cancer

A well-known private healthcare group, Fortis on Friday inaugurated a state-of-the-art facility for the specialised treatment of blood cancers and disorders, which it said "represented a critical step" in addressing the urgent need for comprehensive holistic care. The Fortis Institute of Blood Disorders also integrates paediatric and geriatric care, advanced transplant procedures, and hematopathology expertise, all under one roof, Fortis Healthcare said in a release. The Institute also launched CAR-T cell therapy to its extensive network of Bone Marrow Transplant centres in Mohali, Delhi, Gurgaon, Noida, Mumbai and Bangalore, the statement said. This initiative is supported by a commercial collaboration with ImmunoACT, an IIT-Bombay spin-off and pioneer in India's first fully indigenous and commercially approved gene-modified cell therapy. The NexCAR19, India's first market-authorised CAR-T cell therapy, offers a new ray of hope for treating B-cell lymphomas and B-acute lymphoblast

Multi-cancer blood test shows promise of quicker diagnosis in UK: NHS

A National Health Service (NHS) trial of a new blood test for more than 50 types of cancer has shown promise after it correctly revealed two out of every three cancers in people who had visited their general practitioner (GP) with suspected symptoms in England or Wales, the University of Oxford researchers said on Friday. The so-called Galleri test also correctly identified the original site of cancer in 85 per cent of those cases in what has been described as the first large-scale evaluation of a multi-cancer early detection (MCED) test in individuals who presented to their GP for diagnostic follow-up for suspected cancer. The SIMPLIFY study enrolled 6,238 patients, aged 18 and older, who were referred for urgent imaging, endoscopy or other diagnostic modalities to investigate symptoms suspicious for possible gynaecological, lung, lower GI or upper GI cancer, or who had presented with non-specific symptoms. New tools that can both expedite cancer diagnosis and potentially avoid ...

Indian startup PredOmix develops AI-based blood test to detect 32 cancers

The company's OncoVeryx-F is a patented technology that combines metabolomics (study of small molecules) and AI to identify metabolite signatures of multiple cancers in a single test

Now, a blood test can screen 8 common types of cancer long before symptoms

Cancers of ovary, liver, stomach, pancreas, esophagus, colorectum, lung or breast were detected

A cheap blood test that can track cancer spread

The test requires a fraction of a tube of blood and can detect genetic mutations in DNA